Health
-
BYD cars get high-temperature disinfection feature via system update
BYD said recently that in order to achieve protection for users, BYD has added "high temperature disinfection function" through an OTA update for the cars' system.
-
What happens if a coronavirus vaccine is never developed?
As countries lie frozen in lockdown and billions of people lose their livelihoods, public figures are teasing a breakthrough that would mark the end of the crippling coronavirus pandemic: a vaccine.
-
Coronavirus can cause deadly blood clots in the lungs, study finds
The new coronavirus attack on the body is so complex that it can cause a cascade of unexpected symptoms and complications that can be fatal.
-
Which countries have not reported Covid-19 cases?
The novel coronavirus pneumonia (Covid-19) epidemic has spread to more than 200 countries and regions worldwide but confirmed cases of novel coronavirus pneumonia have not yet been reported in some countries and regions.
-
Coronavirus pandemic likely to last two years until heard immunity, report says
The coronavirus pandemic is likely to last as long as two years and won't be controlled until about two-thirds of the world's population is immune, a group of experts said in a report.
-
Gut flora may predict susceptibility to Covid-19
A new study found that gut flora is positively correlated with human pro-inflammatory factors, which may underlie the susceptibility to severe novel coronavirus pneumonia in healthy individuals.
-
Covid-19: Ebook launched on how to run Fangcang shelter hospitals
An ebook on Alibaba's Global MediXchange to help governments and front line medical professionals set up and operate 'Fangcang Shelter Hospitals' has been recently launched.
-
Chinese company's N95 mask doesn't affect face unlock
For many smartphone users, especially iPhone users, an embarrassing problem is the inability to use face recognition when wearing a mask. While some user feedback over months of learning, Face ID seems to work, there are not many success stories.
-
Gilead says remdesivir coronavirus drug trial show 'positive data'
Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a 5-day dosage of antiviral drug remdesivir improved and more than half were discharged from the hospital within two weeks.
-
Researchers crack Covid-19 genetic signature using AI, identify origin
Using machine learning, a team of Western computer scientists and biologists have identified an underlying genomic signature for 29 different Covid-19 DNA sequences.